skip to content

Cambridge Stem Cell Institute

 
Read more at: Launch of Discovery Research Platform for Tissue Scale Biology
DRP

Launch of Discovery Research Platform for Tissue Scale Biology

1 July 2024

Today (1 July 2024) marks the official start of the Discovery Research Platform for Tissue Scale Biology (DRP-TSB) at the Cambridge Stem Cell Institute. With funding from Wellcome, the platform will work over the next seven years to drive new waves of discovery and translational science into the ways stem cells build...


Read more at: Celebrating the Institute and collaborators at the 2024 CSCI Annual Retreat
Collage of Retreat photos

Celebrating the Institute and collaborators at the 2024 CSCI Annual Retreat

24 June 2024

This month, the Institute held the CSCI Annual Retreat on 6 and 7 June in Cambridge. This annual event brings together CSCI researchers, Affiliate Group Leaders, and our Stem Cells Interdisciplinary Research Centre members for a day and a half of talks, posters, Institute updates, and networking outside of the office and...


Read more at: Immune response study from Teichmann Lab and collaborators explain why some people don't get COVID-19
Immune test. Credit: Imperial College London

Immune response study from Teichmann Lab and collaborators explain why some people don't get COVID-19

20 June 2024

Scientists in Cambridge and London have discovered novel immune responses that help explain how some individuals avoid getting COVID-19. Using single-cell sequencing, researchers from the Wellcome Sanger Institute, University College London (UCL) and Imperial College London (ICL), the Netherlands Cancer Institute and their...


Read more at: Zilbauer Group’s lab-grown ‘mini-guts’ could help in development of new and more personalised treatments for Crohn’s disease
 image of a patient derived, human intetstial organoid.

Zilbauer Group’s lab-grown ‘mini-guts’ could help in development of new and more personalised treatments for Crohn’s disease

11 June 2024

Epigenetic changes to DNA help explain differences in disease severity in patients Cambridge scientists from the Zilbauer Lab at Cambridge Stem Cell Institute (CSCI) have grown ‘mini-guts’ in the lab to help understand Crohn’s disease, showing that ‘switches’ that modify DNA in gut cells play an important role in the...


Read more at: SCI-TIF gather for 2nd Annual Networking Dinner
Collage of photos from the networking dinner

SCI-TIF gather for 2nd Annual Networking Dinner

16 May 2024

This month the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF ) gathered to celebrate their 2 nd Annual Networking Dinner. SCI-TIF members, CSCI Principal Investigators , and Stem Cell Interdisciplinary Research Centre members got together at SIX Restaurant at the Varsity to meet, discuss...


Read more at: CSCI Postgraduates take a break from the bench at this year's Postgraduate Away Day
Collage of photos from the 2024 Postgraduate Away Day

CSCI Postgraduates take a break from the bench at this year's Postgraduate Away Day

7 May 2024

Recently the CSCI PhD and MPhil students got together for their annual Postgraduate Away Day for a day of talks, brainstorming sessions, and a pub quiz. The event, planned by the student committee, took place on 25 April. The 25 new students from the October 2023 intake (pictured) under the supervision of 16 different PIs...


Read more at: ‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention in new study by the Khaled Group
Immune cell exhaustion observed in breast tissue from carriers of BRCA1 and BRCA2 mutations long before breast cancer develops. Credit: Sara Pensa

‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention in new study by the Khaled Group

28 March 2024

Researchers at CSCI and University of Cambridge have created the world’s largest catalogue of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations. The study, published today (28 March) in the journal Nature Genetics from r esearchers in the Khaled Group in the...


Read more at: CSCI Hot Topic Event covers AI’s impact on stem cell research & medicine
Collage of photos from the event - exhibition tables, reception, and panel discussion

CSCI Hot Topic Event covers AI’s impact on stem cell research & medicine

20 March 2024

This week (Monday 18 March) , members of the Cambridge Stem Cell Institute, the Technology and Innovation Forum ( SCI-TIF ) and guests from around Cambridge convened to delve into the pressing subject of AI’s role in advancing stem cell research and medicine ( see the poster here ). The event began with a welcome by...


Read more at: Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds
A cell aggregation of human pluripotent stem cells and amniotic ectoderm cells. Credit Shota Nakanoh

Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds

8 March 2024

Research published this week in Science Advances by Dr Shota Nakanoh in a collaboration between Dr Teresa Rayon’s lab at the Institute and Professor Ludovic Vallier’s lab at the Wellcome-MRC Cambridge Stem Cell Institute has determined that the degree of cell crowding in the early human embryo influences whether cells...


Read more at: New UKRI funding co-led by Walid Khaled will support research into better health, ageing, and wellbeing

New UKRI funding co-led by Walid Khaled will support research into better health, ageing, and wellbeing

12 February 2024

Professor Walid Khaled from CSCI and co-leader Dr Laura Greaves from Newcastle have received UKRI funding for research on age-related biological changes in model organisms as part of a national collaboration. UKRI funding of £3 million is awarded today (12 February) to support a new research cluster as part of the MRC...